Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

Volume 13(2) 2008 (9)

#858108

17 Jun 2008 :   

The association between cytokine gene polymorphisms and kidney allograft survival

Andrzej Pawlik, Leszek Domanski [...]

Ann Transplant 2008; 13(2): 54-58 :: ID: 858108

39 1

#858108

17 Jun 2008 :   

The association between cytokine gene polymorphisms and kidney allograft survival

Andrzej Pawlik, Leszek Domanski, Jacek Rozanski, Bogusław Czerny, Zygmunt Juzyszyn, Grażyna Dutkiewicz, Marek Myslak, Maciej Hałasa, Marcin Słojewski, Ewa Dąbrowska-Zamojcin

Ann Transplant 2008; 13(2): 54-58 :: ID: 858108

39 1

#858107

17 Jun 2008 :   

Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients

Hakeam A. Hakeam, Ahmed H. Al-Jedai [...]

Ann Transplant 2008; 13(2): 46-53 :: ID: 858107

56 2

#858107

17 Jun 2008 :   

Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients

Hakeam A. Hakeam, Ahmed H. Al-Jedai, Syed M. Raza, Khalid Hamawi

Ann Transplant 2008; 13(2): 46-53 :: ID: 858107

56 2

#858106

17 Jun 2008 :   

Transjugular Intrahepatic Porto-Caval Shunt (TIPS) in treatment of portal hypertension in liver transplant recipiens

Tadeusz Wróblewski, Olgierd Rowiński [...]

Ann Transplant 2008; 13(2): 42-45 :: ID: 858106

46 3

#858106

17 Jun 2008 :   

Transjugular Intrahepatic Porto-Caval Shunt (TIPS) in treatment of portal hypertension in liver transplant recipiens

Tadeusz Wróblewski, Olgierd Rowiński, Jerzy Żurakowski, Bogna Ziarkiewicz-Wróblewska, Krzysztof Zieniewicz, Paweł Nyckowski, Marek Krawczyk

Ann Transplant 2008; 13(2): 42-45 :: ID: 858106

46 3

#858105

17 Jun 2008 :   

Non-resectable hepatic tumors in children – role of liver transplantation

Piotr Kaliciński, Hor Ismail [...]

Ann Transplant 2008; 13(2): 37-41 :: ID: 858105

48 8

#858105

17 Jun 2008 :   

Non-resectable hepatic tumors in children – role of liver transplantation

Piotr Kaliciński, Hor Ismail, Dorota Broniszczak, Joanna Teisserye, Ludmiła Bacewicz, Małgorzata Markiewicz-Kijewska, Marek Szymczak, Paweł Nachulewicz, Bożenna Dembowska-Bagińska, Przemysław Kluge, Andrzej Kościesza, Adam Kowalski, Marek Stefanowicz, Weronika Kasprzyk, Marek Krawczyk

Ann Transplant 2008; 13(2): 37-41 :: ID: 858105

48 8

#858104

17 Jun 2008 :   

Human Leukocyte Antigen (HLA) B-27 and older age are associated with augmented cyclosporine blood bioavailability in renal allograft recipients: An attempt toward individualization of immunosuppression

Eghlim Nemati, Saeed Taheri [...]

Ann Transplant 2008; 13(2): 32-36 :: ID: 858104

31 1

#858104

17 Jun 2008 :   

Human Leukocyte Antigen (HLA) B-27 and older age are associated with augmented cyclosporine blood bioavailability in renal allograft recipients: An attempt toward individualization of immunosuppression

Eghlim Nemati, Saeed Taheri, Vahid Pourfarziani, Behzad Einollahi

Ann Transplant 2008; 13(2): 32-36 :: ID: 858104

31 1

#858103

17 Jun 2008 :   

Liver transplantation for fulminant Wilson’s disease in children

Małgorzata Markiewicz-Kijewska, Marek Szymczak [...]

Ann Transplant 2008; 13(2): 28-31 :: ID: 858103

28 0

#858103

17 Jun 2008 :   

Liver transplantation for fulminant Wilson’s disease in children

Małgorzata Markiewicz-Kijewska, Marek Szymczak, Hor Ismail, Sylwester Prokurat, Joanna Teisseyre, Piotr Socha, Irena Jankowska, Anna Chyżyńska, Piotr Kaliciński, Marek Migdał

Ann Transplant 2008; 13(2): 28-31 :: ID: 858103

28 0

#858102

17 Jun 2008 :   

“Transplantation” research output by Muslim Nations: Current status, trends and future outlook

Mohammad Hossein Nourbala, Saeed Taheri [...]

Ann Transplant 2008; 13(2): 21-27 :: ID: 858102

11 0

#858102

17 Jun 2008 :   

“Transplantation” research output by Muslim Nations: Current status, trends and future outlook

Mohammad Hossein Nourbala, Saeed Taheri, Ruhollah Habibi, Ehsan Abolhasani, Eghlim Nemati, Vahid Pourfarziani, Shahin Abbaszadeh, Behzad Einollahi

Ann Transplant 2008; 13(2): 21-27 :: ID: 858102

11 0

#858101

17 Jun 2008 :   

Morphological features and differential diagnosis of hepatitis C recurrence after liver transplantation – literature review and results of single transplantation center

Bogna Ziarkiewicz-Wróblewska, Tadeusz Wróblewski [...]

Ann Transplant 2008; 13(2): 12-20 :: ID: 858101

42 0

#858101

17 Jun 2008 :   

Morphological features and differential diagnosis of hepatitis C recurrence after liver transplantation – literature review and results of single transplantation center

Bogna Ziarkiewicz-Wróblewska, Tadeusz Wróblewski, Aleksander Wasiutyński

Ann Transplant 2008; 13(2): 12-20 :: ID: 858101

42 0

#858100

17 Jun 2008 :   

Non invasive assessment of liver fibrosis

Hanni Yeshua, Ran Oren

Ann Transplant 2008; 13(2): 5-11 :: ID: 858100

36 1

#858100

17 Jun 2008 :   

Non invasive assessment of liver fibrosis

Hanni Yeshua, Ran Oren

Ann Transplant 2008; 13(2): 5-11 :: ID: 858100

36 1

Volume 13(2) 2008 (9) Supplement

#880210

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari,

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

13 0

#880210

Drug lymphocyte level: New perspective in clinical immunosuppression monitoring

A. Barbari

Ann Transplant 2008; 13(1): 43-43 :: ID: 880210

13 0

#880211

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar [...]

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

3 0

#880211

Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers

Z. Marchewka, J. Kuźniar, K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger

Ann Transplant 2008; 13(1): 43-43 :: ID: 880211

3 0

#880208

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro [...]

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

2 0

#880208

Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration

L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi

Ann Transplant 2008; 13(1): 42-42 :: ID: 880208

2 0

#880209

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde [...]

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

21 0

#880209

Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation

J. M. Kovarik, K. Budde, J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten

Ann Transplant 2008; 13(1): 42-42 :: ID: 880209

21 0

#880206

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova [...]

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

12 0

#880206

Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)

E. Wieland, M. Shipkova, Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht

Ann Transplant 2008; 13(1): 41-41 :: ID: 880206

12 0

#880207

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot [...]

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

4 0

#880207

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

4 0

#880203

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa [...]

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

4 0

#880203

Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?

H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova

Ann Transplant 2008; 13(1): 40-40 :: ID: 880203

4 0

#880204

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska [...]

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

1 0

#880204

Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufficiency

M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak

Ann Transplant 2008; 13(1): 40-40 :: ID: 880204

1 0

#880205

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło [...]

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

3 0

#880205

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

3 0

#880201

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg [...]

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

17 0

#880201

Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool

J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz

Ann Transplant 2008; 13(1): 39-39 :: ID: 880201

17 0

#880202

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica [...]

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

5 0

#880202

Therapeutic Drug Monitoring of tacrolimus in renal transplant patients

B. Solnica, K. Słowińska-Solnica, E. Ignacak, J. W. Naskalski

Ann Transplant 2008; 13(1): 39-40 :: ID: 880202

5 0

#880198

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock [...]

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

11 0

#880198

Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation

C. Seger, M. Bock, K. Tentschert, A. Griesmacher

Ann Transplant 2008; 13(1): 38-38 :: ID: 880198

11 0

#880199

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel [...]

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

2 0

#880199

Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)

M. T. Rabuñal Álvarez, E. Fernández Gabriel, M. Outeda Macías, I. Martín Herranz

Ann Transplant 2008; 13(1): 38-38 :: ID: 880199

2 0

#880200

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek [...]

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

4 0

#880200

Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients

D. Kamińska, M. Kuriata-Kordek, M. Boratyńska, K. Falkiewicz, M. Klinger

Ann Transplant 2008; 13(1): 38-39 :: ID: 880200

4 0

#880196

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana [...]

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

13 0

#880196

Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions

T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring

Ann Transplant 2008; 13(1): 37-37 :: ID: 880196

13 0

#880197

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet [...]

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

15 0

#880197

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet, H. Ait-Youcef

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

15 0

#880193

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis [...]

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

13 0

#880193

Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles

N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger

Ann Transplant 2008; 13(1): 36-36 :: ID: 880193

13 0

#880192

29 Sep 2008 :   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri,

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

3 0

#880192

29 Sep 2008 :   

The role of genetics and pharmacogenetic monitoring in transplantation

M. Masri

Ann Transplant 2008; 13(1): 35-35 :: ID: 880192

3 0

#880189

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens [...]

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

3 0

#880189

In vivo hepatic CYP3A4 activity is significantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients

H. de Jonge, M. Naesens, K. Verbeke, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 34-34 :: ID: 880189

3 0

#880190

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide [...]

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

4 0

#880190

In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay

R.l Kato, M. Nishide, C. Kodzu, Y. Ijiri, K. Tanaka

Ann Transplant 2008; 13(1): 34-34 :: ID: 880190

4 0

#880191

The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 34-35 :: ID: 880191

18 0

#880187

The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients

H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers

Ann Transplant 2008; 13(1): 33-33 :: ID: 880187

3 0

#880188

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo [...]

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

11 0

#880188

The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients

A. Provenzani, M. Notarbartolo, F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro

Ann Transplant 2008; 13(1): 33-33 :: ID: 880188

11 0

#880186

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre,

Ann Transplant 2008; 13(1): 32-32 :: ID: 880186

12 0

#880186

Modified release formulation in immunotherapy – the tacrolimus case

N. Undre

Ann Transplant 2008; 13(1): 32-32 :: ID: 880186

12 0

#880185

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 31-31 :: ID: 880185

11 0

#880185

Generic substitution of immunosuppressive drugs – requirements for an equivalent product

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 31-31 :: ID: 880185

11 0

#880184

Generic products – requirements for drug registration

P. K. Kunicki,

Ann Transplant 2008; 13(1): 30-30 :: ID: 880184

6 0

#880184

Generic products – requirements for drug registration

P. K. Kunicki

Ann Transplant 2008; 13(1): 30-30 :: ID: 880184

6 0

#880183

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq,

Ann Transplant 2008; 13(1): 29-29 :: ID: 880183

4 0

#880183

Therapeutic drug monitoring of immunosuppressive drugs – future perspectives

P. Wallemacq

Ann Transplant 2008; 13(1): 29-29 :: ID: 880183

4 0

#880182

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers,

Ann Transplant 2008; 13(1): 28-28 :: ID: 880182

3 0

#880182

Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring

D. R. Kuypers

Ann Transplant 2008; 13(1): 28-28 :: ID: 880182

3 0

#880180

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud,

Ann Transplant 2008; 13(1): 26-26 :: ID: 880180

3 0

#880180

Therapeutic drug monitoring of sirolimus and everolimus

E.M. Billaud

Ann Transplant 2008; 13(1): 26-26 :: ID: 880180

3 0

#880179

Therapeutic drug monitoring of tacrolimus

P. Wallemacq,

Ann Transplant 2008; 13(1): 25-25 :: ID: 880179

5 0

#880179

Therapeutic drug monitoring of tacrolimus

P. Wallemacq

Ann Transplant 2008; 13(1): 25-25 :: ID: 880179

5 0

#880178

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 24-24 :: ID: 880178

13 0

#880178

Therapeutic drug monitoring of ciclosporin

A. Johnston, D. W. Holt

Ann Transplant 2008; 13(1): 24-24 :: ID: 880178

13 0

#880176

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet,

Ann Transplant 2008; 13(1): 22-22 :: ID: 880176

10 0

#880176

Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs

P. Marquet

Ann Transplant 2008; 13(1): 22-22 :: ID: 880176

10 0

#880175

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

Ann Transplant 2008; 13(1): 21-21 :: ID: 880175

2 0

#880175

What can we learn from proficiency testing of immunosuppressive drug assays?

D. W. Holt, A. Johnston

Ann Transplant 2008; 13(1): 21-21 :: ID: 880175

2 0

#880174

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer,

Ann Transplant 2008; 13(1): 20-20 :: ID: 880174

12 0

#880174

Immunoassays for immunosuppressive drugs – benefi ts and risks

W. Steimer

Ann Transplant 2008; 13(1): 20-20 :: ID: 880174

12 0

#880171

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich,

Ann Transplant 2008; 13(1): 17-17 :: ID: 880171

13 0

#880171

Biomarkers - as an adjunct to immunosuppressive drug monitoring

M. Oellerich

Ann Transplant 2008; 13(1): 17-17 :: ID: 880171

13 0

#880170

PK/PD modelling of immunosuppressive agents

E. Wyska,

Ann Transplant 2008; 13(1): 16-16 :: ID: 880170

14 0

#880170

PK/PD modelling of immunosuppressive agents

E. Wyska

Ann Transplant 2008; 13(1): 16-16 :: ID: 880170

14 0

#880169

Drug transporters for immunosuppressive agents

I.A.M. MacPhee,

Ann Transplant 2008; 13(1): 15-15 :: ID: 880169

3 0

#880169

Drug transporters for immunosuppressive agents

I.A.M. MacPhee

Ann Transplant 2008; 13(1): 15-15 :: ID: 880169

3 0

#880168

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink,

Ann Transplant 2008; 13(1): 13-14 :: ID: 880168

4 0

#880168

Pharmacogenetics in immunotherapy: present knowledge and future perspectives

D. A. Hesselink

Ann Transplant 2008; 13(1): 13-14 :: ID: 880168

4 0

#880167

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

Ann Transplant 2008; 13(1): 12-12 :: ID: 880167

3 0

#880167

Pharmacokinetic principles of immunosuppressive-drugs

K. Budde, P. Glander

Ann Transplant 2008; 13(1): 12-12 :: ID: 880167

3 0

#880166

Clinical immunosuppression – current status

M. Klinger,

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

3 0

#880166

Clinical immunosuppression – current status

M. Klinger

Ann Transplant 2008; 13(1): 11-11 :: ID: 880166

3 0

#880165

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet,

Ann Transplant 2008; 13(1): 10-10 :: ID: 880165

8 0

#880165

New insight of immunosuppressive drugs related nephrotoxicity

E. Thervet

Ann Transplant 2008; 13(1): 10-10 :: ID: 880165

8 0

#880164

Organ transplantation in Poland

M. Durlik,

Ann Transplant 2008; 13(1): 9-9 :: ID: 880164

3 0

#880164

Organ transplantation in Poland

M. Durlik

Ann Transplant 2008; 13(1): 9-9 :: ID: 880164

3 0

In Press

20 Jan 2022 : Original article  

Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Ki...

Ann Transplant In Press; DOI: 10.12659/AOT.934850  

19 Jan 2022 : Original article  

Carbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in He...

Ann Transplant In Press; DOI: 10.12659/AOT.933420  

18 Jan 2022 : Original article  

PLGA+Fe₃O₄+PFP Nanoparticles Drug-Delivery Demonstrates Potential Anti-Tumor Effects on Tumor Cells

Ann Transplant In Press; DOI: 10.12659/AOT.933246  

17 Jan 2022 : Original article  

Impact of Thyroid Incidentaloma on Liver Transplant: A Study of 1010 Recipients at a Single Center

Ann Transplant In Press; DOI: 10.12659/AOT.934988  

Most Viewed Current Articles

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

22 Dec 2021 : Original article  

Comparison of Coronary Artery Calcium Scoring with Dobutamine Stress Echo for Detection of Coronary Artery ...

DOI :10.12659/AOT.934163

Ann Transplant 2021; 26:e934163

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

01 Dec 2021 : Original article  

Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-S...

DOI :10.12659/AOT.934175

Ann Transplant 2021; 26:e934175

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358